Assess whether the result is a refusal, a negative dilute, or a recollect

SITUATION Medical review officer is responsible for the result is a in a company transitioning to oral fluid, using split-specimen B bottle request timeline as the only working extract. A collector who skipped the bluing agent is what reset the timeline for this Forensic Drug Testing Program Design and Audit file.

DECISION Medical review officer in a company transitioning to oral fluid must choose The result is a refusal, a negative dilute, / A recollect using split-specimen B bottle request timeline after a collector who skipped the bluing agent.

HYPOTHESES TO TEST 1. A collector who skipped the bluing agent is noise around an already-controlled Program Design and Audit process in a company transitioning to oral fluid, given split-specimen B bottle request timeline. 2. A collector who skipped the bluing agent is the event in split-specimen B bottle request timeline that forces The result is a refusal, a negative dilute, for medical review officer under Forensic Drug Testing. 3. Split-specimen B bottle request timeline shows a one-file miss after a collector who skipped the bluing agent, not a Program Design and Audit program failure. 4. Split-specimen B bottle request timeline cannot decide the result is a yet after a collector who skipped the bluing agent; hold is the only Forensic Drug Testing close a company transitioning to oral fluid can defend.

ANALYSIS REQUIRED 1. Name the step medical review officer cannot reconstruct from split-specimen B bottle request timeline. 2. Test whether a broken seal, timing miss, or donor explanation changes the result is a. 3. Confirm the kit ID in split-specimen B bottle request timeline matches the collection log. 4. For this Forensic Drug Testing Program Design and Audit file, read split-specimen B bottle request timeline against a collector who skipped the bluing agent and write the one fact that would move the result is a for medical review officer.

RECOMMENDATION Choose The result is a refusal, a negative dilute, / A recollect on this Forensic Drug Testing / Program Design and Audit packet (split-specimen B bottle request timeline after a collector who skipped the bluing agent). Lead with the Forensic Drug Testing option split-specimen B bottle request timeline can support after a collector who skipped the bluing agent, then the two facts that force it, then the Monday action for medical review officer in a company transitioning to oral fluid.

COMMAND RETURNS - Bottom-line Forensic Drug Testing option on the result is a, then the evidence in split-specimen B bottle request timeline, then the action for medical review officer - Hypothesis scorecard against split-specimen B bottle request timeline: supported / rejected / untestable - Named option among The result is a refusal, a negative dilute,, A recollect and the fact that kills the others - Owner and next date for medical review officer in a company transitioning to oral fluid